Kamada (KMDA) Change in Account Payables (2012 - 2026)
Kamada (KMDA) posted quarterly Change in Account Payables of -$1.4 million for Q1 2026, up 61.42% year-on-year from -$895803.0 in Q1 2025, and up 57.13% on a QoQ basis from -$3.4 million in Q4 2025.
Kamada (KMDA) Change in Account Payables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Account Payables for 15 consecutive years, with -$1.4 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables rose 61.42% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (down 172.94% YoY) and the FY2025 annual result came in at -$6.9 million, down 660.36% from the prior year.
- Change in Account Payables rose to -$1.4 million in Q1 2026 per KMDA's latest filing, from -$3.4 million in the prior quarter.
- Over the last five years, Change in Account Payables for KMDA reached as high as $12.0 million in Q4 2024 and fell as low as -$13.6 million in Q1 2022.
- A 5-year average of -$905753.8 and a median of -$6712.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 985417.24% — and 2024, when it tumbled 130784.98%.
- Year by year, Change in Account Payables stood at $1160.0 in 2022, then surged by 985417.24% to $11.4 million in 2023, then advanced by 4.73% to $12.0 million in 2024, then plunged by 128.17% to -$3.4 million in 2025, then soared by 57.13% to -$1.4 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.4 million, -$3.4 million, and $634000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Sep 30, 2025 | 634,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Mar 31, 2025 | -3.75 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | -8.79 Mn |
| Mar 31, 2024 | -8.79 Mn |
| Dec 31, 2023 | 11.43 Mn |
| Dec 31, 2023 | 11.43 Mn |